0 70

Cited 0 times in

Corrigendum to “Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy”: Annals of Oncology 2020; 31, suppl.4: S472 (abstr. 540P)

Authors
 S. V. Liu  ;  F. De Braud  ;  A. Drilon  ;  R. C. Doebele  ;  M. R. Patel  ;  B. C. Cho  ;  M. J. Ahn  ;  C. H. Chiu  ;  A. F. Farago  ;  K. Goto  ;  J. Lee  ;  Y. Ohe  ;  S. H. I. Ou  ;  P. Cassier  ;  D. S. W. Tan  ;  G. A. Otterson  ;  L. Veronese  ;  S. Osborne  ;  B. Simmons  ;  S. Siena 
Citation
 ANNALS OF ONCOLOGY, Vol.32(4) : 577-577, 2021-04 
Journal Title
ANNALS OF ONCOLOGY
ISSN
 0923-7534 
Issue Date
2021-04
DOI
10.1016/j.annonc.2021.01.008
Appears in Collections:
6. Others (기타) > Severance Hospital (세브란스병원) > 1. Journal Papers
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/190979
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links